Summary of Shouxiangu’s 2025 Semi-Annual Report
Summary of the 2025 Semi-Annual Report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
Company code: 603896 Company abbreviation: Shouxiangu Bond code: 113660 Bond abbreviation: Shou 22 convertible bonds
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
ZhejiangShouxianguPharmaceuticalCo.,Ltd.
(No. 10, Shangcheng Road, Hushan Street, Wuyi County, Zhejiang Province)
2025
Summary of semi-annual report
August 28, 2025
Summary of the 2025 Semi-Annual Report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
Section 1 Important Tips
1.1 The summary of this semi-annual report comes from the full text of the semi-annual report. In order to fully understand the company's operating results, financial status and future development plans, investors should go to www.sse.com.cn to read the full text of the semi-annual report carefully. 1.2 The company’s board of directors, board of supervisors and directors, supervisors and senior managers guarantee the authenticity, accuracy and completeness of the contents of the semi-annual report and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability. 1.3 All directors of the company shall attend the board meeting.
1.4 This semi-annual report has not been audited.
1.5 There is no profit distribution plan for this reporting period or a plan for converting public reserve funds into share capital approved by the board of directors.
Summary of the 2025 Semi-Annual Report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
Section 2 Basic Information of the Company
2.1 Company Profile
Company Stock Profile
Stock type Stock listing exchange Stock abbreviation Stock code Stock abbreviation before change A shares Shanghai Stock Exchange Shouxiangu 603896/
Contact and Contact Information Board Secretary Securities Affairs Representative
Name Liu Guofang Liu Jia
Phone 0579-87622285 0579-87622285
Office address No. 12, Huanglong 3rd Road, Wuyi County, Zhejiang Province No. 12, Huanglong 3rd Road, Wuyi County, Zhejiang Province
Email [email protected] [email protected]
2.2 Main financial data
Unit: Yuan Currency: RMB At the end of the previous year, the end of this reporting period was higher than the end of this reporting period.
After adjustment Before adjustment Year-end increase or decrease (%) Total assets 3,263,637,736.15 3,131,807,017.80 3,131,185,579.81 4.21 Attributable to listed companies
2,311,679,934.95 2,291,287,346.15 2,294,019,344.33 0.89Shareholders’ net assets
The same period last year and this reporting period compared with the same period last year and this reporting period
After adjustment Before adjustment Increase or decrease in the same period (%) Operating income 299,683,685.70 358,941,052.69 352,585,671.98 -16.51 Total profit 65,695,913.28 99,325,142.76 100,836,263.67 -33.86 belongs to listed companies
65,558,637.69 99,310,066.78 100,873,320.70 -33.99Shareholders’ net profit
Belong to listed companies
Shareholders’ deductions are not
35,824,360.12 84,599,684.53 85,171,951.58 -57.65 Net profit from regular gains and losses
Run
arising from business activities
122,994,078.52 129,175,435.64 128,648,618.02 -4.79 Net cash flow
Weighted average net assets decreased by 1.64 year-on-year
2.82 4.46 4.53
Yield (%) Basic earnings per share in percentage points (yuan
0.33 0.50 0.51 -34.00/share)
Diluted earnings per share (yuan
0.33 0.50 0.51 -34.00/share)
Summary of the 2025 Semi-Annual Report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
2.3 List of shareholdings of the top 10 shareholders
Unit: Total number of shareholders (households) as of the end of the reporting period 23,739 Total number of preference shareholders (households) whose voting rights have been restored as of the end of the reporting period 0 Shareholding status of the top 10 shareholders
Limited holding
Shareholding ratio Shareholding Pledged, marked or frozen name of shareholder Nature of shareholder Conditions for sale
Example (%) Number of shares of quantity
Number of shares
Zhejiang Shouxiangu Investment Management Co., Ltd. Domestic non-state-owned
28.61 56,711,239 0 None 0 Co., Ltd. Legal person
Li Zhenhao Domestic natural person 7.59 15,041,650 0 N/A 0 Li Zhenyu Domestic natural person 4.58 9,078,961 0 N/A 0 Xu Meiyun Domestic natural person 1.43 2,833,900 0 N/A 0 Fang Zhengshun Domestic natural person 1.31 2,600,100 0 N/A 0 Zhong Jinqiang Domestic natural person 0.89 1,770,000 0 None 0 Wang Ying Domestic natural person 0.84 1,669,183 0 None 0 Industrial and Commercial Bank of China Co., Ltd.
Company-Rongtong Health Industry Spirit
Others 0.61 1,200,000 0 None 0 Active allocation of mixed securities investment
fund
Du Hongping Domestic natural person 0.50 1,000,000 0 None 0 Bank of Ningbo Co., Ltd.
- Dongfanghong Zhiyuan held for three years Others 0.49 978,730 0 None 0-phase hybrid securities investment fund
- The Li Mingyan family (Li Mingyan, Zhu Huizhao, Li Zhenhao, and Li Zhenyu) are the joint actual controllers of the company. The above four people directly or indirectly hold a total of 40.78% of the company's equity. Among them, Li Mingyan and Zhu Huizhao are husband and wife, Li Zhenhao and Li Zhenyu are brothers, and Li Zhenhao,
Li Zhenyu is the son of Li Mingyan and Zhu Huizhao. Li Mingyan and Zhu Huizhao respectively hold 65.00% and 35.00% of the equity interests of the controlling shareholder Shouxiangu Investment, Li Zhenhao and Li Zhenyu, who are related to the above-mentioned shareholder relationships or Yixiangu Investment, and are the persons acting in concert;
Wang Ying is the niece of Li Mingyan and Zhu Huizhao; Wang Ying, Li Zhenhao and Li Zhenyu are cousins;
Except for the above circumstances, the company is not aware of the related relationships and concerted actions among other shareholders.
situation.
Preferred shares with restored voting rights
Not applicable
Description of the number of shares held by Donghe
Summary of the 2025 Semi-Annual Report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
2.4 The total number of preference shareholders and the top 10 preference shareholders as of the end of the reporting period □ Applicable √ Not applicable
2.5 Changes in controlling shareholders or actual controllers
□Applicable √Not applicable
2.6 Corporate bonds existing on the date of approval of the semi-annual report □Applicable √Not applicable
Summary of the 2025 Semi-Annual Report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
Section 3 Important Matters
The company shall, in accordance with the principle of materiality, explain the major changes in the company's operating conditions during the reporting period, as well as the matters that occurred during the reporting period that have a significant impact on the company's operating conditions and are expected to have a significant impact in the future.
□Applicable √Not applicable